CD98hc-AGR2 binding leads to increased xCT activity and intracellular level of reduced GSH and promotes CRC liver metastasis through MAPK/ERK and RhoA/Rho-associated protein kinase 2 (ROCK2) pathway (106). Here, AGR2 is linked to colorectal carcinoma.